Correlation Between SentinelOne and Genscript Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both SentinelOne and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SentinelOne and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SentinelOne and Genscript Biotech, you can compare the effects of market volatilities on SentinelOne and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SentinelOne with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of SentinelOne and Genscript Biotech.

Diversification Opportunities for SentinelOne and Genscript Biotech

-0.09
  Correlation Coefficient

Good diversification

The 3 months correlation between SentinelOne and Genscript is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding SentinelOne and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and SentinelOne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SentinelOne are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of SentinelOne i.e., SentinelOne and Genscript Biotech go up and down completely randomly.

Pair Corralation between SentinelOne and Genscript Biotech

Taking into account the 90-day investment horizon SentinelOne is expected to generate 0.96 times more return on investment than Genscript Biotech. However, SentinelOne is 1.04 times less risky than Genscript Biotech. It trades about 0.06 of its potential returns per unit of risk. Genscript Biotech is currently generating about -0.01 per unit of risk. If you would invest  1,425  in SentinelOne on August 25, 2024 and sell it today you would earn a total of  1,429  from holding SentinelOne or generate 100.28% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.8%
ValuesDaily Returns

SentinelOne  vs.  Genscript Biotech

 Performance 
       Timeline  
SentinelOne 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in SentinelOne are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, SentinelOne unveiled solid returns over the last few months and may actually be approaching a breakup point.
Genscript Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genscript Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

SentinelOne and Genscript Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with SentinelOne and Genscript Biotech

The main advantage of trading using opposite SentinelOne and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SentinelOne position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.
The idea behind SentinelOne and Genscript Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Other Complementary Tools

CEOs Directory
Screen CEOs from public companies around the world
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing